Why the study?
Do rotavirus vaccines reduce hospital admissions and mortality due to gastroenteritis in children <5 years of age?
Do rotavirus vaccines reduce hospital admissions and mortality due to gastroenteritis in children <5 years of age?
Rotavirus vaccines have significantly reduced hospitalizations and mortality associated with severe dehydrating gastroenteritis globally.
Supports rotavirus vaccination programs; leaves open mortality effects and generalizability beyond Australia.
Rotavirus, the commonest cause of severe dehydrating gastroenteritis world-wide, was discovered less than 50 years ago. It causes about 450,000 deaths per year in children <5 years of age and hospitalises millions more. Rotavirus vaccines have been shown to have a major impact on hospital admissions due to rotavirus gastroenteritis and all-cause gastroenteritis and reduce mortality in developing countries. In Australia, there has been a 71% decrease in rotavirus hospitalisations in children 0-5 years of age. From the discovery of rotavirus as the major causative agent for severe gastroenteritis, through vaccine development and vaccine post-marketing surveillance activities, Australian scientists and clinicians have played a significant role in the global effort to reduce the burden of rotavirus infection.
No takes yet. Share an insight, caveat, or question.
Bines et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: